Liquidia has received tentative approval from the US Food and Drug Administratio...
On July 2024, Colombia's President Gustavo Petro signed Law 2386 of 2024, which ...
China’s National Medical Products Administration (NMPA) Center for Drug Evaluati...
Adcendo will acquire ex-China global rights for Multitude’s tissue factor-target...
The FDA approval of Imfinzi in this indication comes a month after the agency ca...
Bavarian Nordic aims to gain a label expansion for adolescents in Europe in Q4 t...
The Phase III inMIND trial evaluating Monjuvi as a combination treatment in rela...
The FDA rejected the therapy after the AdCom raised efficacy and ethical concern...
Hoth Therapeutics has announced a master services agreement with Aronnax to adva...
The US Food and Drug Administration (FDA) has accepted for priority review the n...
Genomic medicines offer new techniques for treating conditions once thought to b...
UK-based biotechnology company Nuntius Therapeutics has announced a strategic co...
AstraZeneca has received priority review from the US Food and Drug Administratio...
While the vaccine demonstrated high responses for neutralizing influenza A titer...
As part of pipeline reprioritisation, Acelyrin has dropped izokibep and will ins...
In 2021, the Centers for Disease Control and Prevention estimated that 49 percen...
